Business
Voyageur Announces the Postponement of Filing Annual Financial Statements and MD&A due to COVID-19 related delays. Reschedules for April 3, 2020
(via TheNewswire) CALGARY, Alberta - TheNewswire - March 27 th , 202...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Announces the Postponement of Filing Annual Financial Statements and MD&A due to COVID-19 related delays. Reschedules for April 3, 2020(via TheNewswire)\n \n \nCALGARY, Alberta - TheNewswire - March 27th, 2020 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the \"Company\" or \"Voyageur\") (formally Voyageur Minerals Ltd.) announces the postponement of filing its annual financial statements (\"Financial Statements\") and its annual management's discussion & analysis (\"MD&A\") for the year ended November 30, 2019 due to logistics and delays caused by the COVID-19. Voyageur will invoke the Alberta Securities Commission (the \"Commission\") blanket order 51-517 (the \"Blanket Order\") for temporary exemption from certain corporate finance requirements.\n\n\n \nRecent events pertaining to COVID-19 has impacted the Company, its employees and its directors' ability to rely on timely information and meet to approve its Financial Statements and MD&A. \n\n\n \nAccording to the Blanket Order, during the period from March 23, 2020 to June 1, 2020 a person or company required to make certain filings as described in the Blanket Order has an additional 45 days from the deadline otherwise applicable under Alberta securities laws to make the filing according to certain disclosure obligations by the Company. \n\n\n \nPursuant to the Blanket Order, Voyageur is relying on the relief therein for its Financial Statements required by section 4.2 of National Instrument 51-102 and its MD&A required by subsection 5.1(2) of National Instrument 51-102.\n\n\n \nUntil Voyageur has filed and announced the required Financial Statements and MD&A, all management and other insiders are subject to Voyageur's share trading and black-out policy that reflects the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.\n\n\n \nVoyageur estimates that the required disclosure required by Alberta securities laws will be filed no later than April 3, 2020.\n\n\n \nThere have been no material business developments since the date of the last interim financial statements were filed on October 30, 2019.\n\n\n \nAbout Voyageur\n\n\n \nVoyageur Pharmaceuticals Ltd. is Canadian public company listed on the TSX Venture Exchange under the trading symbol VM. Voyageur is focu...